IP Library › Granted Patent US 11,395,583
Granted Patent B2
US 11,395,583 · App. 17/040,615 · Granted Jul 26, 2022

Endoscope light emitting device, endoscope using same, and fluorescence imaging method

Inventors: Takeshi Abe (Osaka, JP); Shozo Oshio (Osaka, JP)
Assignee: Panasonic Intellectual Property Management Co., Ltd.
A61B1/0684A61B1/043A61B1/0653A61B1/07G02B23/2461
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,395,583
App. No.
17/040,615
Granted
Jul 26, 2022
Kind
B2
Abstract

An endoscope light emitting device ( 1 ) is a light emitting device for use in a fluorescence imaging method. The endoscope light emitting device includes: a solid-state light emitting element ( 2 ); and a wavelength converter ( 3 ) including a first phosphor ( 4 ) that emits first wavelength-converted light ( 7 ), wherein the first wavelength-converted light has a light component across at least a whole of a wavelength range of 700 nm or more and 800 nm or less. An endoscope ( 11 ) includes the endoscope light emitting device. A fluorescence imaging method is a method using the endoscope light emitting device or the endoscope, and includes the steps of: administering a fluorescent drug to a subject; and applying the first wavelength-converted light ( 7 ) to the subject with whom the fluorescent drug has made contact.

Claims (22)

1. An endoscope light emitting device comprising:

a solid-state light emitting element; and

a wavelength converter including a first phosphor that emits a first wavelength-converted light,

wherein the first wavelength-converted light has a light component across at least a whole of a wavelength range from 700 nm to 800 nm,

wherein the first wavelength-converted light has a fluorescence peak within a wavelength range from 600 nm to 800 nm, and

wherein the endoscope light emitting device is used for a fluorescence imaging method.

2. The endoscope light emitting device according to claim 1 , wherein the first wavelength-converted light has a light component across a whole of a wavelength range from 600 nm to 800 nm.

3. The endoscope light emitting device according to claim 1 , wherein the wavelength converter further includes a second phosphor that absorbs the primary light emitted by the solid-state light emitting element and emits a second wavelength-converted light that is visible light.

4. The endoscope light emitting device according to claim 3 , wherein the first phosphor emits the first wavelength-converted light by absorbing at least one of the primary light and the second wavelength-converted light.

5. The endoscope light emitting device according to claim 3 ,

wherein a peak of the fluorescence emitted by the second phosphor remains within a wavelength range from 500 nm to 700 nm, and

wherein the solid-state light emitting element includes a blue laser element as an excitation source.

6. The endoscope light emitting device according to claim 1 , wherein the first phosphor includes at least one of a Eu 2+ -activated phosphor and a Ce 3+ -activated phosphor.

7. The endoscope light emitting device according to claim 1 , wherein the solid-state light emitting element radiates a laser light having a maximum intensity value within a wavelength range from 430 nm to 480 nm, from 500 nm to 560 nm, or from 600 nm to 700 nm.

8. An endoscope comprising the endoscope light emitting device according to claim 1 .

9. The endoscope according to claim 8 , further comprising a detector that detects fluorescence emitted from a fluorescent drug that has absorbed the first wavelength-converted light.

10. A fluorescence imaging method using the endoscope according to claim 8 , the fluorescence imaging method comprising:

administering a fluorescent drug to a subject; and

applying the first wavelength-converted light to the subject with whom the fluorescent drug has made contact.

11. A fluorescence imaging method using the endoscope light emitting device according to claim 1 , the fluorescence imaging method comprising:

administering a fluorescent drug to a subject; and

applying the first wavelength-converted light to the subject with whom the fluorescent drug has made contact.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: ABE, TAKESHI; OSHIO, SHOZO
To: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
Reel/Frame 054836/0408 →
Priority Claims (2)
JP JP2018-061256 · Mar 28, 2018 · national
JP JP2018-191630 · Oct 10, 2018 · national
Continuity (1)
Related Publication 20210113076A1 · Apr 22, 2021